2019 Lung Injury Response Understanding Vaping Practices in the United States

ICR 201911-0920-010

OMB: 0920-1276

Federal Form Document

Forms and Documents
Document
Name
Status
Form and Instruction
New
Form and Instruction
New
Supplementary Document
2019-11-25
Supplementary Document
2019-11-25
Supplementary Document
2019-11-25
Supplementary Document
2019-11-22
Supplementary Document
2019-11-22
Supplementary Document
2019-11-22
Supplementary Document
2019-11-22
Supplementary Document
2019-11-22
Supplementary Document
2019-11-22
Supplementary Document
2019-11-22
Supplementary Document
2019-11-22
Supporting Statement B
2019-11-25
Supporting Statement A
2019-11-25
ICR Details
0920-1276 201911-0920-010
Historical Active
HHS/CDC 0920-20DC
2019 Lung Injury Response Understanding Vaping Practices in the United States
New collection (Request for a new OMB Control Number)   No
Emergency 11/25/2019
Approved with change 11/26/2019
Retrieve Notice of Action (NOA) 11/25/2019
  Inventory as of this Action Requested Previously Approved
02/29/2020 3 Months From Approved
126,000 0 0
5,000 0 0
0 0 0

The goal of this emergency data collection is to conduct a formative study to collect data from individuals who vape/dab tetrahydrocannabinol (THC) but who have not developed lung injury in order to compare characteristics with those who have developed the injury to help further the ongoing public health investigation.
I have determined that this information must be collected prior to the expiration of time periods established under Part 1320, and that this information is essential for CDC’s emergency response in the investigation of e-cigarette, or vaping, product use associated lung injury (EVALI) , and to assist each state/local/territory jurisdiction in making rapid, practical decisions for actions to prevent and control this public health problem. CDC cannot reasonably comply with the normal clearance because our initial investigation suggests that collection of data comparing cases of people who report vaping THC but have not developed EVALI in a timely way is essential for narrowing the list of products, substances, and risk factors requiring further public health investigation and action (e.g., prioritizing samples for laboratory testing). Because the collection of data is expected to begin as soon as possible, accelerated OMB review is requested. Therefore, CDC requests a 90-day emergency clearance to launch collection of data.

US Code: 42 USC 241 Name of Law: PHSA
  
None

Not associated with rulemaking

No

2
IC Title Form No. Form Name
Understanding Vaping Practices in the United States Survey Survey EVALI Survey
Understanding Vaping Practices in the United States Survey Survey EVALI Survey

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 126,000 0 0 126,000 0 0
Annual Time Burden (Hours) 5,000 0 0 5,000 0 0
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
No
This is a New Emergency ICR.

$104,232
Yes Part B of Supporting Statement
    No
    No
No
No
No
Uncollected
Kevin Joyce 404 639-1944 kdj7@cdc.gov

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
11/25/2019


© 2024 OMB.report | Privacy Policy